Teva Pharmaceutical And Chemical Industries India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -0.78%
(FY 2023)
- Profit -2.52%
(FY 2023)
- Ebitda -0.23%
(FY 2023)
- Net Worth 3.08%
(FY 2023)
- Total Assets 0.15%
(FY 2023)
About Teva Pharmaceutical And Chemical Industries India
The Corporate was formerly known as Teva Pharmaceuticals And Chemical Industries India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinod Shetty, Vishal Bhargava, and Nishank Bhargava serve as directors at the Company.
- CIN/LLPIN
U24230MH2003FTC326703
- Company No.
326703
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
02 May 2003
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Teva Pharmaceutical And Chemical Industries India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishank Bhargava  | Director | 23-Feb-2022 | Current |
| Vinod Shetty | Director | 31-Jul-2021 | Current |
| Vishal Bhargava | Director | 26-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Teva Pharmaceutical And Chemical Industries India.
Teva Pharmaceutical And Chemical Industries India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.78% decrease. The company also saw a slight decrease in profitability, with a 2.52% decrease in profit. The company's net worth moved up by a moderate rise of 3.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teva Pharmaceutical And Chemical Industries India?
In 2023, Teva Pharmaceutical And Chemical Industries India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tevapharm India Private LimitedActive 24 years 19 daysVinod Shetty and Nishank Bhargava are mutual person
Actavis Pharma Development Centre Private LimitedActive 18 years 4 monthsVinod Shetty and Nishank Bhargava are mutual person
Teva Global Business Services Private LimitedActive 20 years 4 monthsVinod Shetty and Nishank Bhargava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Teva Pharmaceutical And Chemical Industries India?
Unlock and access historical data on people associated with Teva Pharmaceutical And Chemical Industries India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teva Pharmaceutical And Chemical Industries India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teva Pharmaceutical And Chemical Industries India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
